title: Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1.
abstract: Epidemiological and experimental reports have linked mild-to-moderate wine and/or grape consumption to a lowered incidence of cardiovascular, cerebrovascular, and peripheral vascular risk. This study revealed that resveratrol, an enriched bioactive polyphenol in red wine, selectively induces heme oxygenase 1 (HO1) in a dose- and time-dependent manner in cultured mouse cortical neuronal cells and provides neuroprotection from free-radical or excitotoxicity damage. This protection was lost when cells were treated with a protein synthesis or heme oxygenase inhibitor, suggesting that HO1 induction is at least partially required for resveratrol's prophylactic properties. Furthermore, resveratrol pretreatment dose-dependently protected mice subjected to an optimized ischemic-reperfusion stroke model. Mice in which HO1 was selectively deleted lost most, if not all, of the beneficial effects. Together, the data suggest a potential intracellular pathway by which resveratrol can provide cell/organ resistance against neuropathological conditions.
authors.affiliation: Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.
authors.forename: Yoshihito
authors.initials: Y
authors.lastname: Sakata
authors.forename: Hean
authors.initials: H
authors.lastname: Zhuang
authors.forename: Herman
authors.initials: H
authors.lastname: Kwansa
authors.forename: Raymond C
authors.initials: RC
authors.lastname: Koehler
authors.forename: Sylvain
authors.initials: S
authors.lastname: Doré
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D015153:Blotting, Western; D002540:Cerebral Cortex / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D051547:Heme Oxygenase-1 / Q000235:genetics / Q000378:metabolism*; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D018696:Neuroprotective Agents / Q000494:pharmacology; D000077185:Resveratrol; D018709:Statistics, Nonparametric; D013267:Stilbenes / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D018696:Neuroprotective Agents; D013267:Stilbenes; D051547:Heme Oxygenase-1; D000077185:Resveratrol
references.citation: Mol Med. 1999 Oct;5(10):656-63
references.pmid: 10602774
references.citation: Ageing Res Rev. 2008 Jan;7(1):43-8
references.pmid: 17913594
references.citation: J Neurosci Res. 2007 Aug 15;85(11):2433-40
references.pmid: 17600836
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2445-50
references.pmid: 10051662
references.citation: Nat Rev Drug Discov. 2006 Jun;5(6):493-506
references.pmid: 16732220
references.citation: Food Chem Toxicol. 1995 Dec;33(12):1061-80
references.pmid: 8847003
references.citation: J Cardiovasc Pharmacol. 2000 Feb;35(2):263-8
references.pmid: 10672859
references.citation: PLoS One. 2008 Jun 04;3(6):e2264
references.pmid: 18523577
references.citation: Brain Res. 2004 Aug 13;1017(1-2):98-107
references.pmid: 15261105
references.citation: Mol Cell Biol. 2003 Jan;23(1):38-54
references.pmid: 12482959
references.citation: Clin Chim Acta. 1995 Mar 31;235(2):207-19
references.pmid: 7554275
references.citation: Am J Surg. 2000 Nov;180(5):357-61
references.pmid: 11137687
references.citation: Ann N Y Acad Sci. 2003 May;993:276-86; discussion 287-8
references.pmid: 12853318
references.citation: Lancet. 1993 Apr 24;341(8852):1103-4
references.pmid: 8097009
references.citation: Nat Prod Rep. 1996 Aug;13(4):265-73
references.pmid: 8760864
references.citation: J Stroke Cerebrovasc Dis. 2006 Jul-Aug;15(4):133-8
references.pmid: 17904065
references.citation: Lancet. 1992 Jun 20;339(8808):1523-6
references.pmid: 1351198
references.citation: Can J Physiol Pharmacol. 2009 Apr;87(4):275-86
references.pmid: 19370081
references.citation: Endocr Metab Immune Disord Drug Targets. 2008 Jun;8(2):89-98
references.pmid: 18537695